Medtronic vs Stryker

Medtronic (MDT), health care, and Stryker (SYK), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

Medtronic is worth $132.1B on the stock market and Stryker $120.1B: Medtronic is valued at 10% more. Medtronic trades at 25.4 times earnings and Stryker at 33.6; operating margins in their latest fiscal years were 17.8% and 19.5%. Over the past year Medtronic's share price has moved +2.06% and Stryker's -13.6%.

Key facts

Medtronic market value
$132.1B
Stryker market value
$120.1B
Medtronic P/E
25.4
Stryker P/E
33.6
Medtronic revenue
$36.4BFY to 2026-04-24
Stryker revenue
$25.1BFY to 2025-12-31
Superinvestors holding both
2

Market values as of .

Medtronic vs Stryker: every measure side by side
Measure Medtronic Stryker
SectorHealth CareHealth Care
Country Ireland United States
Fiscal year ends2026-04-242025-12-31
Size
Market cap$132.1Bhigher$120.1Blower
Revenue$36.4Bhigher$25.1Blower
Earnings$4.8Bhigher$3.2Blower
Employees95,000higher56,000lower
Total assets$93Bhigher$47.8Blower
Valuation
P/E25.4lower33.6higher
P/S3.6lower4.8higher
P/B—5.1
Dividend yield—1.13%
Profitability
Operating margin17.8%lower19.5%higher
Balance sheet
Net assets$49.5Bhigher$22.4Blower
Total liabilities$43Bhigher$25.4Blower
Total debt$28Bhigher$15.9Blower
Cash on hand$1.9Blower$4Bhigher
Price change
Today+0.38%lower+1.53%higher
1 year+2.06%higher-13.6%lower

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

Loading the one-year price chart…

Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

Percentages are each holding's share of that investor's reported portfolio (under "Both": Medtronic / Stryker). Who owns MDT · Who owns SYK

Further comparisons

Learn

Questions and answers

Which is bigger, Medtronic or Stryker?

By market value, Medtronic is the larger: $132.1B against $120.1B for Stryker. By revenue in its latest fiscal year, Medtronic is the larger: $36.4B against $25.1B for Stryker.

Which has the higher P/E ratio?

Stryker: 33.6, against 25.4 for Medtronic. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.

Which has the higher operating margin?

Stryker: 19.5%, against 17.8% for Medtronic. Operating margin is operating income as a share of revenue in the latest fiscal year.

Which has more debt?

Medtronic: $28B, against $15.9B for Stryker. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.

Which superinvestors own both Medtronic and Stryker?

In their latest 13F filings, Diamond Hill team and Mairs & Power team hold both.

Cite this page

Funkfolio, “Medtronic vs Stryker”, data as of 17 November 2026. https://funkfolio.com/compare/mdt-vs-syk

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.